RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 96.45
+1.08 (1.13%)
At close: Dec 5, 2025
RemeGen Market Cap
RemeGen has a market cap or net worth of 50.36 billion as of December 5, 2025. Its market cap has increased by 240.54% in one year.
Market Cap
50.36B
Enterprise Value
51.36B
Revenue
2.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
96.45
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 50.36B, an increase of 76.56%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 50.36B | 282.71% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 409.56B |
| WuXi AppTec | 269.53B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.27B |
| Shanghai United Imaging Healthcare | 107.10B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |